BACKGROUND
The risk of venous thromboembolic events (VTE) in relation to orthopaedic surgery is considerable. Traditionally the highest risk of VTE was seen in patients who had lower limb arthroplasty procedures [1] . In order to help reduce the risk of VTE, there is a vogue in UK hospitals for inpatients to have risk assessment and expedite commencement of pro phylaxis [2] . As a result VTE assessment and prophylaxis is an integral part of patient safety, and can help clinicians and hospitals reduce exposure to litigation and financial penalties [3] .
There is evidence suggesting a link between lower limb cast immobilisation and VTE in the out patient setting [4] . The incidence of Deep Venous Throm bosis (DVT) in patients with temporary lower limb immobilisation is considerable and varies from 5-39% depending on the type of immobilisation and patient factors [4] [5] [6] . Given the obvious risks of lower limb cast immobilisation it appears that the same emphasis is not placed on VTE assessment in outpatients that are treated for lower limb trauma with cast im mobilisation. Recently published guidelines suggest that ambulatory patients with cast immo bilisation should be assessed for their risk of developing VTE and prophylactic treatment offered [7] .
A simple and cost-effective VTE risk screening tool utilised during clinic can improve patient safety and assist clinicians in mitigating medico-legal risk. We introduced and implemented a VTE risk as ses sment and management tool in orthopaedic fracture clinics that was based on recent good practice guidelines published by the College of Emergency Medi cine [UK] . It involved a VTE risk assessment pathway printed on a single page proforma that was attached to the front of patient case notes by clinic staff to any patient attending the senior author's Orthopaedic fracture clinic. The clinicians in these clinics were thus reminded to follow the screening tool at the beginning of clinics and manage patients as per the specified pathway.
The aim of this study was to assess the effectiveness of this new VTE assessment tool and how successfully it has been implemented.
MATERIAL AND METHODS
The VTE risk assessment pathway was based on guidelines for the use of thromboprophylaxis in ambu latory trauma patients requiring temporary limb immobilisation published by the College of Emergency Medicine (UK) [7] . This was printed and attached to the front of patient case notes by clinic staff to any patient attending the orthopaedic fracture clinic of the senior author (Fig. 1) . The clinicians in these fracture clinics were asked to follow the pathway and document its use when seeing patients with lower limb trauma. The printed pathway attached speci fically to the front of the notes aimed to act as a memory aid to the clinicians.
According to the VTE pathway, any patient over the age of sixteen that presented with lower limb trauma requiring rigid cast immobilisation or altered weight bearing status should be evaluated for VTE prophylaxis using Dalteparin. If no contraindication to chemical prophylaxis was identified, the need for prophylaxis should be discussed with the patient and their acceptance or refusal of prophylaxis would be documented in the clinical notes. Patients deemed to require prophylaxis would have it prescribed by the clinician seeing the patient and they would be given 5000 units of Dalteparin once per day for the duration of cast immobilisation. When VTE prophylaxis was prescribed, base line blood tests were taken including full blood count, Urea and electrolytes and liver function tests. Patients were asked to contact their general practitioner for repeat blood tests 2 weeks later or have the bloods repeated at a subsequent fracture clinic to ensure there was no evidence of Heparin induced thrombocytopenia [HIT] . Additionally, a dictat ed letter was sent to the patient's general practitioner as a safety net to help ensure patients would be screened for the HIT in the community.
We retrospectively assessed a cohort of patients who had lower limb trauma necessitating limb im mobilisation over a 4 month period, before the screen ing tool was implemented. These patients were identified from plaster room prescription sheets. Following identification of this cohort clinical letters were reviewed to determine the documentation of assessment and treatment of patients at risk of VTE events. A pros pective data collection was then undertaken in ortho paedic fracture clinic once implementation of the new VTE assessment tool had occurred. The screening tool was used as an aid by the clinician to help identify patients at risk of VTE, allowing for instigation of treatment when indicated. The proformas were collected at the end of each clinic and data analysed to assess the effectiveness and compliance with as sess ment of VTE risk and appropriate management. The approval for the work was obtained through our local institutions R&D department.
Statistical analysis
Data was collated in Microsoft Excel 2007 and analysed using Statsdirect statistical software version 2.8.0. The dataset was deemed to be categorical data and there fore analysed using Fisher's exact test. Sta tistical significance was established at the P<0.05 level.
RESULTS
58 patients were included in this study. 28 pa tients were in the pre-tool group and 30 patients in the posttool group. The average patient age in the pre-tool group was 45.3 years of age (range 20-82 years of age) and in the post-tool group 41.2 years of age (range 17-80). There were 13 males/15 females in the pre-tool group, and 14 males/ 16 females in the post-tool group.
The types of injuries that were treated with lower limb rigid immobilisation in both groups were similar (Fig. 2) .
In the pre-tool group, 5/30 patients were VTE risk assessed. Of these, 4 were treated with VTE pro phylaxis, with 1 declining VTE prophylaxis. In the posttool group, 27/28 patients had VTE risk assessment. Twenty-five had VTE risk assessment in their first clinic visit and 2 in a subsequent clinic visit. Eighteen of the 27 (67%) patients had Dalteparin prescribed as per protocol whilst 9 refused chemical VTE prophylaxis (Tab. 1).
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Tab. 1. Proportion of patients who had VTE risk evaluation between cohorts Fig. 1 . DVT risk assessment tool and treatment algorithm modified from Roberts et al, 2012 [7] 
DISCUSSION
The relationship between immobility and venous thromboembolism (VTE) is well documented [4, 5, 6] . In 2006, up to 62% of British Orthopaedic departments did not routinely use VTE prophylaxis and only 11% performed risk stratification in ambulatory lower limb trauma patients with rigid immobilisation [8] . The UK, France and Germany now have national guidelines which recommend use of VTE prophylaxis in lower limb rigid immobilisation patients [7, 9] .
Developing deep vein thrombosis as a consequence of trauma and cast immobilisation is potentially preventable. Numerous authors have commented on the proportion of DVTs which arise from the distal calf [10] [11] [12] . However, there remains debate over the management of distal calf thrombi and the value in treating distal DVT events [13, 14] . While this treatment debate continues, the sequelae to DVT's are potentially serious and have marked impact on mor bidity [15, 16] . These sequelae can range in severity from ve nous insufficiency, oedema and ulceration to pulmo nary embolism and death [15, 17] .
Further to the release of College of Emergency Medicine [UK] guidelines in 2012, there has been little evidence to demonstrate the efficacy and impact these guidelines can have on orthopaedic clinical practice [7] . These guidelines were designed to be implemented in the acute accident and emergency situation. However, we have shown they are transferable across speciality and can be effectively applied to an orthopaedic fracture clinic.
Since the implementation of the new VTE risk assessment and management tool in the senior author's clinic, there has been a significant increase in the number of patients identified at risk of DVT and having prophylaxis discussed and documented in the clinical notes. Our results show that a simple and cost effective measure such as a printed proforma attached to the front of clinical notes can act as a successful prompt. This tool can also help doctors Fig. 2 . The types of injuries that were seen and treated between the two patient groups to effec tively evaluate and prescribe VTE prophy laxis when indicated in ambulatory patients who undergo treatment with lower limb cast immobilisation.
The effective implementation of the risk assessment tool was of paramount importance in changing clinical practice in this study. We encouraged the use of the tool by giving reminders to doctors and nonmedical staff at the start of clinics. We also ensured that patients were not missed by stipulating the assessment tool should be placed at the front of all clinical notes to help serve as an aide-memoire. Such a memory prompt can be of great value in busy clinics, and in clinics with high turnover of clinical staff (such as teams with trainees). There is a huge step be tween developing clinical guidelines to actually implementing those guidelines, and practical measures that can facilitate such implementation are im portant. This is in line with the challenges faced in im plementing osteoporosis secondary prevention measures in fracture clinics [18, 19, 20, 21, 22 ,23] despite the vast literature supporting the benefits of such mea sures [18, 19, 21, 22, 23, 24, 25] .
CONCLUSION
Our VTE assessment tool can im prove the quality of patient care and may also help ortho pa edic clinicians mitigate the medico-legal implications that currently exist around VTE assessment and prophylaxis in the outpatient fracture clinic setting.
